Dual specificity phosphatase 6 as a new therapeutic target candidate for epithelial ovarian cancer

被引：1
|
作者：
Sato, Seiya [1 ]
Itamochi, Hiroaki [2 ]
机构：
[1] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane, Japan
[2] Iwate Med Univ, Sch Med, Dept Clin Oncol, Yahaba, Iwate, Japan
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
关键词：
ONCOGENE ADDICTION; BEVACIZUMAB; INHIBITION; DUSP6;
D O I：
10.21037/atm.2019.12.105
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
    Xu, Haoya
    Zou, Ruoyao
    Li, Feifei
    Liu, Jiyu
    Luan, Nannan
    Wang, Shengke
    Zhu, Liancheng
    [J]. CANCER MEDICINE, 2021, 10 (11): : 3655 - 3673
  • [42] Notch signaling can be a new therapeutic target for advanced ovarian cancer
    Sugiyama, Mai
    Yoshihara, Masato
    Koya, Yoshihiro
    Kitami, Kazuhisa
    Uno, Kaname
    Iyoshi, Shohei
    Mogi, Kazumasa
    Yokoi, Akira
    Nakamura, Kae
    Nawa, Akihiro
    Kajiyama, Hiroaki
    [J]. CANCER SCIENCE, 2023, 114 : 2065 - 2065
  • [43] New insight into NANOG: A novel therapeutic target for ovarian cancer (OC)
    Mahalaxmi, Iyer
    Devi, Subramaniam Mohana
    Kaavya, Jayaramayya
    Arul, Narayanasamy
    Balachandar, Vellingiri
    Santhy, Kumaran Sivanandan
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 852 : 51 - 57
  • [44] ITLNI identified by comprehensive bioinformatic analysis as a hub candidate biological target in human epithelial ovarian cancer
    Liu, JinHui
    Li, SiYue
    Liang, JunYa
    Jiang, Yi
    Wan, YiCong
    Zhou, ShuLin
    Cheng, WenJun
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2379 - 2392
  • [45] A parental requirement for dual-specificity phosphatase 6 in zebrafish
    Maurer, Jennifer M.
    Sagerstrom, Charles G.
    [J]. BMC DEVELOPMENTAL BIOLOGY, 2018, 18
  • [46] NEW CANDIDATE GENETIC MARKERS ASSOCIATED WITH PROGNOSIS AND CLINICAL CHARACTERISTICS OF EPITHELIAL OVARIAN CANCER
    Vaclavikova, R.
    Elsnerova, K.
    Mohelnikova-Duchonova, B.
    Ehrlichova, M.
    Hlavac, V.
    Gut, I.
    Rob, L.
    Skapa, P.
    Bartakova, A.
    Bouda, J.
    Soucek, P.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 571 - 571
  • [47] Genomic analysis of DUSP6, a dual specificity MAP kinase phosphatase, in pancreatic cancer
    Furukawa, T
    Yatsuoka, T
    Youssef, EM
    Abe, T
    Yokoyama, T
    Fukushige, S
    Soeda, E
    Hoshi, M
    Hayashi, Y
    Sunamura, M
    Kobari, M
    Horii, A
    [J]. CYTOGENETICS AND CELL GENETICS, 1998, 82 (3-4): : 156 - 159
  • [48] USP32 COULD BE A NEW DRUG TARGET FOR EPITHELIAL OVARIAN CANCER
    Nakae, A.
    Kodama, M.
    Hashimoto, K.
    Matsumoto, Y.
    Nakatsuka, E.
    Kawano, M.
    Shimura, H.
    Mabuchi, S.
    Sawada, K.
    Kimura, T.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 784 - 784
  • [49] Role of EZH2 in epithelial ovarian cancer: from biological insights to therapeutic target
    Li, Hua
    Zhang, Rugang
    [J]. FRONTIERS IN ONCOLOGY, 2013, 3
  • [50] CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer
    Kim, Jihye
    Cho, Young-Jae
    Ryu, Ji-Yoon
    Hwang, Ilseon
    Han, Hee Dong
    Ahn, Hyung Jun
    Kim, Woo Young
    Cho, Hanbyoul
    Chung, Joon-Yong
    Hewitt, Stephen M.
    Kim, Jae-Hoon
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Choi, Chel Hun
    Lee, Jeong-Won
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 156 (01) : 211 - 221
12345